Get the Stockscreener App
264.74
5.32%
13.37
Penumbra Inc stock is traded at $264.74, with a volume of 593.61K.
It is up +5.32% in the last 24 hours and up +14.17% over the past month.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
See More
Previous Close:
$251.37
Open:
$253.03
24h Volume:
593.61K
Relative Volume:
1.33
Market Cap:
$10.32B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
249.75
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
+4.63%
1M Performance:
+14.17%
6M Performance:
-9.24%
1Y Performance:
+34.00%
1-Day Range:
$252.74
$268.81
1-Week Range:
$250.56
$268.81
52-Week Range:
$184.80
$310.00
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
264.74 | 9.96B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Healthcare Tech Leader Penumbra Scheduled for Wells Fargo and Morgan Stanley September Conferences - Stock Titan
Will Volume Confirm Reversal in Penumbra Inc.July 2025 Drop Watch & Technical Confirmation Alerts - beatles.ru
Is Penumbra Inc. stock entering bullish territoryTrade Ideas & Long-Term Investment Growth Plans - Newser
Analyzing Penumbra Inc. with multi timeframe charts2025 Institutional Moves & Weekly Chart Analysis and Guides - Newser
Penumbra Inc.’s Price Action Aligns with Quant SignalsMarket Sentiment Review & Risk Controlled Daily Plans - sisaissue.com
How to escape a deep drawdown in Penumbra Inc.Weekly Risk Summary & Free Daily Entry Point Trade Alerts - Newser
How Penumbra Inc. stock performs during market volatilityWeekly Investment Summary & Long-Term Capital Growth Strategies - classian.co.kr
Recovery Signals Appearing in Penumbra Inc. ChartsEarnings Performance Report & Technical Buy Zone Confirmation - beatles.ru
Is Penumbra Inc. reversing from oversold territoryJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Why Penumbra Inc. stock attracts strong analyst attentionBuy Signal & Breakout Confirmation Trade Signals - Newser
Live market analysis of Penumbra Inc.Quarterly Portfolio Report & Reliable Breakout Forecasts - Newser
What to do if you’re stuck in Penumbra Inc.July 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Penumbra Inc. stock outlook for YEARPortfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
Will Penumbra Inc. continue its uptrendWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Key resistance and support levels for Penumbra Inc.2025 Winners & Losers & Risk Managed Investment Strategies - Newser
How to use Fibonacci retracement on Penumbra Inc.2025 Big Picture & Fast Gaining Stock Reports - Newser
What machine learning models say about Penumbra Inc.2025 Major Catalysts & Entry Point Confirmation Signals - Newser
What makes Penumbra Inc. stock price move sharply2025 Pullback Review & Daily Stock Trend Reports - Newser
Yuen, Penumbra CFO, sells $500k in shares By Investing.com - Investing.com South Africa
Arani Bose sells Penumbra shares worth $3m By Investing.com - Investing.com Nigeria
Arani Bose sells Penumbra shares worth $3m - Investing.com India
Yuen, Penumbra CFO, sells $500k in shares - Investing.com
Penumbra Inc. Enters Reversal Setup in Weekly Charts2025 Market Outlook & Precise Entry and Exit Recommendations - metal.it
Cetera Investment Advisers Acquires 1,000 Shares of Penumbra, Inc. (NYSE:PEN) - Defense World
Chart based exit strategy for Penumbra Inc.July 2025 Outlook & Comprehensive Market Scan Reports - Newser
Charles Schwab Investment Management Inc. Raises Stake in Penumbra, Inc. (NYSE:PEN) - Defense World
Insider Transactions Reported | Penumbra(PEN)saw insider trading activity on 8/13/2025 - AInvest
Penumbra Inc director Wilder sells $89k in stock By Investing.com - Investing.com Australia
Penumbra EVP Roberts sells $143k in stock By Investing.com - Investing.com Australia
Penumbra EVP Roberts sells $143k in stock - Investing.com
Penumbra Inc director Wilder sells $89k in stock - Investing.com
Penumbra (PEN) Receives Buy Rating from RBC Capital with $325 Price Target - AInvest
Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know - Yahoo Finance
Penumbra, Inc. shares rise 2.19% intraday after presenting at Canaccord Genuity's 45th Growth Conference. - AInvest
PNC Financial Services Group Inc. Buys 331 Shares of Penumbra, Inc. (NYSE:PEN) - Defense World
Transcript : Penumbra, Inc. Presents at Canaccord Genuity?s 45th Annual Growth Conference, Aug-12-2025 12 - MarketScreener
5 Insightful Analyst Questions From Penumbra’s Q2 Earnings Call - Yahoo Finance
LPL Financial LLC Has $6.79 Million Holdings in Penumbra, Inc. (NYSE:PEN) - Defense World
PEN Q2 Deep Dive: Sales Force Expansion and Clinical Milestones Drive Outperformance - ca.finance.yahoo.com
Penumbra Inc. Added to Custom Quant Screener TodayProfit Target Stock Opportunity Monitor Activated - beatles.ru
Penumbra Inc. Breaks Losing Streak — Is the Trend ReversingWeekly Chart Analysis With Entry Advice Provided - metal.it
Does Penumbra Inc. offer margin of safetyFree Technical Signal Summary - thegnnews.com
Intracranial Stents Market to hit US$ 702.8 million by 2031 | - openPR.com
Penumbra, Inc. (NYSE:PEN) Stock Position Decreased by Mutual of America Capital Management LLC - Defense World
Aspiration Thrombectomy Device Market Set to Witness - openPR.com
Penumbra Inc.: Thrombectomy Business Expansion As a Significant Driver For Overall Market Share Growth! - Smartkarma
MACD Signals Flash Warning for Penumbra Inc. StockOptimized Watchlist With Daily Adjustments Launched - metal.it
Wall Street Zen Downgrades Penumbra (NYSE:PEN) to Hold - Defense World
How volatile is Penumbra Inc. stock compared to the marketAchieve breakthrough growth with proven strategies - Jammu Links News
Is it the right time to buy Penumbra Inc. stockBreakthrough profits - Jammu Links News
What are analysts’ price targets for Penumbra Inc. in the next 12 monthsRapid return acceleration - Jammu Links News
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Penumbra Inc Stock (PEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Yuen Maggie | Chief Financial Officer |
Aug 13 '25 |
Sale |
250.00 |
2,000 |
500,000 |
12,943 |
| Bose Arani | Director |
Aug 13 '25 |
Sale |
250.65 |
12,000 |
3,007,776 |
558 |
| Wilder Thomas | Director |
Aug 12 '25 |
Sale |
240.16 |
372 |
89,340 |
372 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary |
Aug 11 '25 |
Sale |
238.94 |
600 |
143,363 |
65,457 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):